Cargando…
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
BACKGROUND: COVID-19 pandemic has claimed millions of lives and devastated the health service system, livelihood, and economy in many countries worldwide. Despite the vaccination programs in many countries, the spread of the pandemic continues, and effective treatment is still urgently needed. Altho...
Autores principales: | Jitobaom, Kunlakanya, Boonarkart, Chompunuch, Manopwisedjaroen, Suwimon, Punyadee, Nuntaya, Borwornpinyo, Suparerk, Thitithanyanont, Arunee, Avirutnan, Panisadee, Auewarakul, Prasert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206137/ https://www.ncbi.nlm.nih.gov/pubmed/35717393 http://dx.doi.org/10.1186/s40360-022-00580-8 |
Ejemplares similares
-
Human Schlafen 11 inhibits influenza A virus production
por: Jitobaom, Kunlakanya, et al.
Publicado: (2023) -
Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition
por: Niyomdecha, Nattamon, et al.
Publicado: (2020) -
Rapid and Efficient Cell-to-Cell Transmission of Avian Influenza H5N1 Virus in MDCK Cells Is Achieved by Trogocytosis
por: Kongsomros, Supasek, et al.
Publicado: (2021) -
Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
por: Kongsomros, Supasek, et al.
Publicado: (2021) -
Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)